Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

02/20 09:17   RUSSIA, SAUDI ARABIA NEGOTIATING DEVELOPMENT OF FULL-SCALE MILITARY-TECHNICAL COOPERATION - FEDERAL SERVICE FOR MILITARY-TECHNICAL COOPERATION
 
02/20 09:11   FSMTC denies delivery of Russian tanks, warplanes to Iran
 
02/20 09:08   FEDERAL SERVICE FOR MILITARY-TECHNICAL COOPERATION DENIES DELIVERY OF RUSSIAN TANKS, WARPLANES TO IRAN
 
02/20 09:00   INTERFAX RUSSIA AND FSU GENERAL NEWS
 
02/20 08:27   Results of forex trading on Moscow Exchange on February 17
 
02/20 05:05   Russia political and economic calendar: February 20
 
02/20 05:00   INTERFAX RUSSIA AND CIS BUSINESS AND FINANCIAL NEWS
 
02/19 20:57   Protesters stir up clash with police in Kyiv
 
02/19 20:37   Actions dedicated to anniversary of 2014 events end peacefully in Kyiv
 
02/19 18:19   Russia records 8 truce breaches, Turkey 13 in Syria in past 24 hrs
 


 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

February 20, 2017
 
09:00
INTERFAX RUSSIA AND FSU GENERAL NEWS
 
08:27
Results of forex trading on Moscow Exchange on February 17
 
05:05
Russia political and economic calendar: February 20
 
05:00
INTERFAX RUSSIA AND CIS BUSINESS AND FINANCIAL NEWS
 
February 19, 2017
 
20:57
Protesters stir up clash with police in Kyiv
 
20:37
 
18:19
Russia records 8 truce breaches, Turkey 13 in Syria in past 24 hrs
 
17:48
'Coal blockade' protesters threaten to block rail traffic between Ukraine, Russia
 
16:14
Orthodox Church warns Russians against militaristic rhetoric
 
15:50
Russian Church accuses opponents of St. Isaac's Cathedral handover of attempting to "rock the boat"
 
15:36
Rally in support of Rustavi 2 TV channel in Tbilisi ends without incident
 
14:50
Over 3 bln rubles to be invested in overhaul of Tor missile system's maker by 2019
 
14:31
DPR claims to have repelled Ukrainian military attack
 
14:19
"Non-social-parasites" march in Gomel passes without incident
 
 more headlines 



Interviews
 

.
OSCE Chairperson-in-Office, Austrian Foreign Minister Sebastian Kurz has given an interview to Interfax in which he speaks about his vision of the Ukrainian settlement and the role of the SMM OSCE in it, about conditions under which EU sanctions against Russia can be lifted at any time and tells about what he values in his Russian counterpart Sergei Lavrov.

more
.
.
Pakistani Minister of Planning, Development and Reform Ahsan Iqbal has given an interview to Interfax in the wake of his visit to Moscow in which he speaks about prospects of interaction between Russia and Pakistan in various spheres, prospects of Russias joining the China-Pakistan economic corridor project, the settlement in Afghanistan and prospects of Pakistans joining the Nuclear Non-proliferation Treaty.

more
.
.
Head of the delegation of the International Committee of the Red Cross (ICRC) in Russia, Belarus and Moldova Magne Barth has explained the position of the ICRC on interaction with Russian military in Syria. Earlier the Russian Defense Ministry called the ICRC reaction regarding the death of two Russian medical workers in a strike on a Russian military hospital in Syrias Aleppo cynical.

more

 
  
 ©   1991—2017   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100